نتایج جستجو برای: ژن flt3

تعداد نتایج: 19081  

Hossein Ayatollahi, Hossein Rahimi, Mohammad Hadi Sadeghian, Mohammad Mehdi Kooshyar, Mohammad Reza Keramati, Sepideh Shakeri, Seyyede Fatemeh Shams,

Background and Aims: Multiple myeloma is a malignant proliferation of plasma cells derived from a single clone. The tumor, its products and the host response lead to organ damages. Some factors that are responsible in its pathogenesis are recognized. As FMS like Tyrosine Kinase 3 receptor (FLT3) mutation has been proved as a determining factor in leukemic patients the goal of this study was to ...

Journal: :BioMedInformatics 2022

Acute myeloid leukemia (AML), a hematologic malignancy that results in bone marrow failure, is the most common acute adults. The presence of FMS-related tyrosine kinase 3 (FLT3) mutations associated with poor prognosis, making evaluation FLT3-inhibitors an imperative goal clinical trials. Midostaurin was first FLT3-inhibitor approved by FDA and EMA for treatment FLT3-mutated AML, it showed sign...

2006
Soheil Meshinchi Todd A. Alonzo Derek L. Stirewalt Michel Zwaan Martin Zimmerman Dirk Reinhardt Gertjan J. L. Kaspers Nyla A. Heerema Robert Gerbing Beverly J. Lange Jerald P. Radich

Activating mutations of the FLT3 gene occur because of an internal tandem duplication of the juxta-membrane domain (FLT3/ITD) or point mutation of the activation loop domain (FLT3/ALM). The presence of FLT3 mutations as well as the allelic ratio of FLT3/ITD (ITD-AR, mutant– wild type ratio) may have prognostic significance. FLT3 mutation status of 630 children with de novo acute myeloid leukemi...

Journal: :Blood 2006
Carola Reindl Ksenia Bagrintseva Sridhar Vempati Susanne Schnittger Joachim W Ellwart Katja Wenig Karl-Peter Hopfner Wolfgang Hiddemann Karsten Spiekermann

In acute myeloid leukemia (AML), two clusters of activating mutations are known in the FMS-like tyrosine kinase-3 (FLT3) gene: FLT3-internal tandem duplications (FLT3-ITDs) in the juxtamembrane (JM) domain in 20% to 25% of patients, and FLT3 point mutations in the tyrosine-kinase domain (FLT3-TKD) in 7% to 10% of patients, respectively. Here, we have characterized a new class of activating poin...

Journal: :Blood 2004
Kazutaka Ozeki Hitoshi Kiyoi Yuka Hirose Masanori Iwai Manabu Ninomiya Yoshihisa Kodera Shuichi Miyawaki Kazutaka Kuriyama Chihiro Shimazaki Hideki Akiyama Miki Nishimura Toshiko Motoji Katsuji Shinagawa Akihiro Takeshita Ryuzo Ueda Ryuzo Ohno Nobuhiko Emi Tomoki Naoe

Although FLT3 mutations are essentially found in myeloid-lineage leukemia cells, a high level of FLT3 expression was recently observed in MLL gene-rearranged acute lymphoblastic leukemia without FLT3 mutations. Here, we analyzed the biologic and clinical significance of the FLT3 transcript level in comparison with several gene alterations in 181 de novo acute myeloid leukemia (AML) cases. The m...

Journal: :iranian biomedical journal 0
مرجان یغمایی marjan yaghmaie کامران علی مقدم kamran alimoghaddam حسین مزدرانی hossein mozdarani اردشیر قوام زاده ardeshir ghavamzadeh مرجان حاج قاسمی marjan hajhashemi مظفر ازنب mozaffar aznab سید حمداله غفاری

background: the secondary genetic changes other than the promyelocytic leukemia-retinoic acid receptor (pml-rara) fusion gene may contribute to the acute promyelocytic leukemogenesis. chromosomal alterations and mutation of flt3 (fms-like tyrosine kinase 3) tyrosine kinase receptor are the frequent genetic alterations in acute myeloid leukemia. however, the prognostic significance of flt3 mutat...

Journal: :Blood 2004
Patrick Brown Soheil Meshinchi Mark Levis Todd A Alonzo Robert Gerbing Beverly Lange Robert Arceci Donald Small

Pediatric acute myelogenous leukemia (AML) has a poor prognosis, and novel therapies are needed. The FLT3 tyrosine kinase represents a promising target in pediatric AML. FLT3 is constitutively activated either by an internal tandem duplication (ITD) or by a point mutation (PM) in 17% to 24% of pediatric AML cases. Autocrine stimulation of wild-type (WT) FLT3 by coexpressed FLT3 ligand (FL) occu...

ژورنال: پیاورد سلامت 2013
اژدری, عبدالطیف, عباسی, سکینه, محمدی, شاهین,

Background and Aim: FLT3 gene is a member of class III receptor Tyrosine Kinase, which is expressed in most patients with acute myeloid leukemia (AML). Mutations of FLT3 such as Internal Tandem Duplication (ITD) and point mutation of the D835 are the most common genetic defects in myeloid leukemia. These two mutations in patients with MLA and their effect on survival rate were studied for the f...

Journal: :Blood 2006
Elke Heiss Kristina Masson Christina Sundberg Malin Pedersen Jianmin Sun Susanne Bengtsson Lars Rönnstrand

Early signal relay steps upon ligand binding to the receptor tyrosine kinase Flt3 (ie, sites of Flt3 autophosphorylation and subsequent docking partners) are mainly unresolved. By immunoprecipitation of specific tryptic peptides contained in the juxtamembrane region of human Flt3 and subsequent radiosequencing, we identified the tyrosine residues 572, 589, 591, and 599 as in vivo autophosphoryl...

Journal: :Blood 2008
Ulrike Bacher Claudia Haferlach Wolfgang Kern Torsten Haferlach Susanne Schnittger

We characterized the mutational status of the FLT3 tyrosine kinase domain (FLT3-TLD) in 3082 patients with newly diagnosed AML. FLT3-TKD mutations were detected in 147 of 3082 (4.8%) patients. Similar to the FLT3 juxtamembrane domain mutations (FLT3-LM), there was a high correlation of FLT3-TKD mutations with normal karyotype (88 of 1472; 6.0%). FLT3-TKD mutations were most frequent in the AML ...

نمودار تعداد نتایج جستجو در هر سال

با کلیک روی نمودار نتایج را به سال انتشار فیلتر کنید